Oaktree Specialty Lending (OCSL) missed Q2 expectations due to a significant drop in net investment income, leading to a 25% cut in its regular dividend. Despite paying a supplemental dividend that reduced the effective cut to 15%, the company faces ongoing challenges with high non-accrual loans and subpar credit quality. OCSL shares trade at a 23% discount to NAV, reflecting elevated credit risk and weak loan origination trends, limiting near-term growth prospects. The forward dividend yield stands at 10%, based on the new regular dividend, with potential supplemental payments possibly increasing this yield.
U-BX Technology's stock fell 15.6% in after-hours trading following the announcement of a 1-for-25 reverse stock split effective Friday. The move will reduce the number of outstanding shares significantly to maintain Nasdaq listing compliance. The co...
Avacta Therapeutics posted a £38.6 million loss for 2025 amid strategic focus on its proprietary pre|CISION® cancer drug platform. The company progressed two clinical-stage programs, AVA6000 and AVA6103, showing promising safety and efficacy data, es...
AI Financial Corp. disclosed that its $706 million WLFI token treasury is locked and unavailable for sale, raising serious liquidity and going concern issues. The company acquired 7.28 billion WLFI tokens in a $1.5 billion deal but the token value ha...
Stellantis announced a new project to produce a small, affordable electric car, called the E-Car, starting in 2028 at its Pomigliano d’Arco plant in Italy. The E-Car aims to revive the small car segment in Europe with a focus on European design, affo...
XRP is seeing a resurgence in retail trading activity, with CryptoQuant data showing increased trading frequency among smaller traders, often a sign of upcoming major price swings. The token recently rose above $1.5, and analysts note its current pri...
